Stephens & Co. Reiterates Overweight on Privia Health Gr, Maintains $26 Price Target

Benzinga · 01/07 13:12
Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $26 price target.